7hon MSNOpinion
FDA quietly says yes to a controversial abortion drug
Abortion. Just saying the word breathes heaviness. Even though there were 609,360 abortions across 48 reporting areas in 2022 ...
The Pigeon Forge Police Department is teaming up with Sevier County CARES to host the Drug Enforcement Administration’s Drug ...
The Drug Enforcement Administration (DEA) has announced that Saturday will be its 29th National Prescription Drug Take Back ...
Cistanche is a supplement that may boost immunity, lower fatigue, and improve memory. Side effects may include nausea, vomiting, abdominal pain, and dizziness.
Detailed price information for Aspire Biopharma Holdings Inc (ASBP-Q) from The Globe and Mail including charting and trades.
This article was reviewed by Sara Harcharik Perkins, MD. Is Minoxidil Safe for Women? Uses, Side Effects, and More Key ...
Self-administration of rozanolixizumab, a neonatal Fc receptor blocker (FcRn) indicated for generalized myasthenia gravis, ...
The Food and Drug Administration is announcing the first round of drugs that will receive drastically expedited reviews at ...
SK Biopharmaceuticals forms a joint venture, Mentis Care, to develop an integrated epilepsy care ecosystem through AI-driven ...
The age of the GLP-1 drug has reached yet another milestone, with the US Food and Drug Administration green-lighting Novo Nordisk's once-daily oral semaglutide pill to treat people at high risk of ...
Gov. Gavin Newsom said Thursday that California will begin selling affordable insulin under its own label on Jan. 1.
Gov. Gavin Newsom announced Thursday that the state would provide insulin shots for $11, far below market prices.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results